tiprankstipranks
TipRanksTop Financial ExpertsInsidersJason Aryeh

Jason Aryeh Insider Profile

25 Followers
Jason Aryeh, Director at Orchestra BioMed Holdings, holds 115.58K shares in Ligand Pharma (Ticker: LGND), holds 69.97K shares in Lifecore Biomedical (Ticker: LFCR), holds 118.12K shares in Orchestra BioMed Holdings (Ticker: OBIO). Most recently, Jason Aryeh Sold ― shares of Ligand Pharma on Jun 12, 2026 for an estimated value of $1.25M.
See the Hottest Stocks Based on Insider Trading >
tipranks
Jason Aryeh

Jason Aryeh
Orchestra BioMed Holdings (OBIO)
Director

Ranked #44,818 out of 108,921 Corporate Insiders

Profitable Transactions

40%
12 out of 30 Profitable Transactions

Average Return

+0.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$34M
97.14%
1.77%
0.91%
0.19%
0.00% Others
A breakdown of Jason Aryeh's holdings
See the Top Stocks by Insiders

Insider Roles

Ligand Pharma
(LGND)
Director
Orchestra BioMed Holdings
(OBIO)
Director
Lifecore Biomedical
(LFCR)
Director
Vaxart
(VXRT)
Director
+1 other positions
Roles that Jason Aryeh holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Orchestra BioMed Holdings
(OBIO)
Rating:Informative Buy
Date:Sep 19, 2025 - Today
Return:+108.10%
The most profitable trade made by Jason Aryeh
See the Latest Stocks Traded by Insiders

Jason Aryeh's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
OBIO
Orchestra BioMed Holdings
May 20, 2026
Director
Informative Buy
2.49K
$600.04K
LFCR
Lifecore Biomedical
Jun 05, 2026
Director
Uninformative Buy
―
$307.85K
LGND
Ligand Pharma
Jun 12, 2026
Director
Informative Sell
1.25M
$33.01M
ARLZQ
Aralez Pharmaceuticals
May 24, 2017
―
Informative Sell
556.48K
$109.57
IMMU
Immunomedics
―
―
―
―
MACK
Merrimack Pharmaceuticals
Jul 18, 2019
―
Informative Buy
1.64K
$57.52K
ANEB
Anebulo Pharmaceuticals
―
Director
―
―
NVLNF
Novelion Therapeutics
May 17, 2017
―
Informative Buy
3.23K
$375.91K
VXRT
Vaxart
Mar 17, 2011
Director
Informative Sell
28.76K
$65.23K
List of latest transactions for each holding click on a transaction to see Jason Aryeh's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Jason Aryeh insider profile FAQ

What is the percentage of profitable transactions made by Jason Aryeh?
The percentage of profitable transactions made by Jason Aryeh is 40%.
    What is the average return per transaction made by Jason Aryeh?
    The average return per transaction made by Jason Aryeh is 0.40%.
      What stocks does Jason Aryeh hold?
      Jason Aryeh holds: OBIO, LFCR, LGND, ARLZQ, IMMU, MACK, ANEB, NVLNF, VXRT stocks.
        What was Jason Aryeh’s latest transaction?
        Jason Aryeh latest transaction was an Informative Sell of $1.25M.
          What was Jason Aryeh's most profitable transaction?
          Jason Aryeh’s most profitable transaction was an Informative Buy of OBIO stock on September 19, 2025. The return on the trade was 108.10%.
            What is Jason Aryeh's role in Orchestra BioMed Holdings?
            Jason Aryeh's role in Orchestra BioMed Holdings is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.